It has been postulated that control or inhibitory mechanisms are important aspects of vital cellular functions (3, 10) . Since enzymatic reactions are basic to cellular metabolism, the inhibition of en zymatic activity probably plays a fundamental role in the regulation of life processes. Comparative studies of malignant and normal cells have also led to the conclusion that the comparable processes in the normal cell are under the control of inhibitory factors (2, 3, 8, 10) . Therefore, because of the key position of desoxyribonucleic acid in the cell, the existence of a specific inhibitor of desoxyribonuclease and its variation under different conditions of cellular activity would be of considerable in terest.
While inhibitors of desoxyribonuclease have been described in yeast (12, 13) , in serum (9) , and in various mammalian tissues (4, 5) , no studies have been reported on the inhibitor in human nor mal and leukemic white blood and bone marrow cells with which this paper is concerned. The pres ent studies suggest that there exists a relationship between the degree of cellular maturity and the amount of inhibitory activity per cell.
METHOD
The viscosimetric technic used for the determi nation of the desoxyribonuclease inhibitor (anti-DN-ase) has been described (7 Received for publication September 4, 1951. cases) was 14.4 per cent Â±4.9 per cent per IO4 cells ( Table 1) . The difference between these two tissues is, obviously, the presence of immature cells in the marrow and of mature cells of the same series in the blood. Hence, the difference in activity of the two types of cell preparations would seem to be due to the difference in cellular maturity between the two.
Lymphosarcoma and Hodgkin's disease.â€"In these two related diseases the inhibitor activity of the blood (nine cases) and the marrow (five cases) was not significantly different from the normal.
Both the blood and marrow were, also, morpho logically quite normal (Table 1) . These data bear out the findings noted above and may, reasonably, be included with them. The smaller standard de viations are probably the result of improvement in technic as the work progressed. Mydocytic leukemia.â€"In five cases of chronic myelocytic leukemia, under treatment, the mean inhibitor activity of the white blood cells was also quite close to normal (Table 2) . Although the total white cell counts varied between 2,500 and 48,000, there were few immature cells present.
However, in two cases of leukemia, in relapse, the increase in the immaturity of the white blood cell pattern was paralleled by a considerable re duction in the inhibitor activity to 10.8 per cent. One of these patients (H.H.) was tested in both conditions, so that a direct comparison is possible (Table 2) .
In contrast to the blood of treated leukemia, which showed a normal cell pattern and inhibitor content, the corresponding bone marrow exhibited a cell pattern of great immaturity and a corre spondingly low inhibitor activity of 6.3 per cent. In leukemia, in relapse, the cellular composition of the blood approximated that of the bone marrow, and, similarly, the inhibitor concentrations were of the same order of magnitude.
In acute leukemia the considerably greater de-gree of cellular immaturity of both the blood and marrow was again paralleled by a further reduction in the amount of inhibitory activity. Here again, the cellular composition and the inhibitor concen tration of both blood cells and marrow cells were of the same order of magnitude. Of interest is the blood inhibitor value in case E.G. which was close to normal when the cellular composition of the blood was not greatly disturbed. It is evident, from these data, that it is not the leukemia, itself, but the state of maturity of the cells that determines the inhibitory activity of the cells. The same conclusion applies to lymphosarcoma and Hodgkin's disease.
Lymphocytic leukemia.â€"In this disease a strik ing contrast is seen between the inhibitory ac tivity of blood and marrow cells in chronic lymphocytic leukemia and in acute lymphocytic leukemia (Table 3 ). In the chronic disease, the relatively high inhibitory activity is associated with an essentially lymphocytic cell pattern. In the acute leukemia, the absence of inhibitory activity is Cancer Research associated with the primitive lymphoblasts char acteristically present. In both cases the similarity in cellular composition of the blood and the mar row is paralleled by a similarity in inhibitory activity. Here, again, it appears that the amount of inhibitor is related to the degree of cellular maturity.
It is of further interest that the blast cells of acute leukemia showed an excess of enzyme, even though large numbers of cells were used per test. Evidently, the inhibitor content is reduced to such an extent that the amount of desoxyribonuclease various mammalian organ tissues, cancer (4, 5) , and also in human white blood and marrow cells, both normal and malignant, would indicate that the inhibitor is of general biological significance. Zamenhof and Chargaff (12) theorize that the in hibitor is an important aspect of the system which regulates the functional activity of desoxyribonucleic acid by controlling the rate of its depolymerization. Of basic importance to this theory is the extent to which desoxyribonucleic acid is involved in cellular processes. It is generally believed that it plays a fundamental role in hereditary processes normally present is demonstrable. The possible alternative, that an increase in enzyme had oc curred without change in the amount of inhibitor, is less likely in light of the fact that Greenstein (6) has been unable to find changes in desoxyribonuclease in malignant tissues. In either case, the physiological or biochemical result would be the same. DISCUSSION The demonstration of an inhibitor of desoxyribonuclease casts light upon a possible mechanism regulating desoxyribonuclease activity (12, 13) . The fact that this inhibitor, or similar ones, are present in a variety of cells, e.g., yeast (12, 13) , (1) and also, possibly, in the metabolic behavior of the cell (2, 11) .
The present demonstration of a relationship be tween the concentration of the inhibitor and the degree of cellular maturity seems to suggest that the inhibitor has a significant role in the processes of cell maturation. Mature blood cells, which have ceased all growth and development, may be con sidered to have done so partly as a consequence of the cessation of desoxyribonucleic acid metabolism brought about by an inhibition of depolymerization. These cells are characterized by an absence of cytoplasmic ribonucleic acid and, it is believed, by a cessation of protein synthesis (11) . On the other hand, immature cells, in which cell multipli cation (with a concomitant increase in the quan tity of nucleoprotein and protein) and maturation are still active show lower concentrations of en zyme inhibitor, which would permit changes in desoxyribonucleic acid to occur at controlled rates of speed. Primitive blast cells, an important char acteristic of which is a maximum rate of nucleo protein production, contain little or no inhibitor, which would permit the above processes to oper ate at maximum speed. This theory, however, rests upon the demonstration that the degradation of desoxyribonucleic acid is a crucial factor in the above processes in which the rate of depolymerization is rate-determining. 3. The above facts are discussed in light of a possible mechanism for the control of cell matura tion and development.
